MedicalResearch.com eInterview with:
Fengcai Zhu
Deputy Director of the Jiangsu Provincial Center for Disease Prevention and Control, Jiangsu provincial center for disease prevention and control
MedicalResearch.com Editor's Note: HFMD = Hand Foot and Mouth Disease
MedicalResearch.com: What are the main findings of the study? Answer: From this trial, the inactivated alum-adjuvant EV71 vaccine showed a good protection for both the EV71-associated HFMD and EV71-associated disease. The vaccine gave 90% protection against clinical EV71-associated HFMD and 80.4% against EV71-associated disease (including neurological complications) for at least 12 months. The safety profile and immunogenicity of this vaccine is proved to be clinical acceptable. We also proposed a titre (1:32) of neutralization antibody as surrogate of protection against EV71-associated disease.MedicalResearch.com eInterview with David Melzer, MBBCH, PhD Professor of Epidemiology and Public Health Medical School - University of Exeter, Barrack Road, Exeter EX2...
MedicalResearch.com eInterview with Muhammad Mamdani Director, Applied Health Research Centre, St. Michael's Hospital Scientist in the Keenan Research Centre of the Li...
MedicalResearch.com eInterview with Luis Beck-da-Silva, MD, ScD Cardiology Division, Heart Failure Clinic Hospital de Clínicas de Porto Alegre Rua Ramiro Barcelos, 2350 Sala...
MedicalResearch.com eInterview with: Christopher J Lindsell, PhD Vice Chair for Research, Department of Emergency Medicine Director of Biostatistics, Epidemiology and Research Design, Center for Clinical...